MX342039B - Composiciones y usos de materiales con actividad antimicrobiana elevada y toxicidad baja referencia cruzada a solicitudes previas. - Google Patents

Composiciones y usos de materiales con actividad antimicrobiana elevada y toxicidad baja referencia cruzada a solicitudes previas.

Info

Publication number
MX342039B
MX342039B MX2013002122A MX2013002122A MX342039B MX 342039 B MX342039 B MX 342039B MX 2013002122 A MX2013002122 A MX 2013002122A MX 2013002122 A MX2013002122 A MX 2013002122A MX 342039 B MX342039 B MX 342039B
Authority
MX
Mexico
Prior art keywords
compositions
materials
antimicrobial activity
low toxicity
high antimicrobial
Prior art date
Application number
MX2013002122A
Other languages
English (en)
Other versions
MX2013002122A (es
Inventor
P Bevilacqua Michael
Bentitez Diego
J Deming Timothy
A Hanson Jarrod
Koziol Lucas
Original Assignee
The Regents Of The Univ Of California *
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Regents Of The Univ Of California * filed Critical The Regents Of The Univ Of California *
Publication of MX2013002122A publication Critical patent/MX2013002122A/es
Publication of MX342039B publication Critical patent/MX342039B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A01N37/18—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing the group —CO—N<, e.g. carboxylic acid amides or imides; Thio analogues thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
    • A23L3/34—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
    • A23L3/3454—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of liquids or solids
    • A23L3/3463—Organic compounds; Microorganisms; Enzymes
    • A23L3/3526—Organic compounds containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

La presente invención se refiere a los agentes antimicrobianos constituidos por copolipéptidos sintéticos mejorados contienen residuos aminoacídicos catiónicos y se pueden basar en una secuencia en bloque. Estos agentes antimicrobianos presentan una toxicidad baja para mamíferos y pueden dar lugar a un autoensamblaje dirigido. Los copolipéptidos sintéticos de la invención son útiles en el tratamiento de heridas y otras infecciones.
MX2013002122A 2010-08-23 2011-08-23 Composiciones y usos de materiales con actividad antimicrobiana elevada y toxicidad baja referencia cruzada a solicitudes previas. MX342039B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37619510P 2010-08-23 2010-08-23
PCT/US2011/048869 WO2012027411A2 (en) 2010-08-23 2011-08-23 Compositions and uses of materials with high antimicrobial activity and low toxicity

Publications (2)

Publication Number Publication Date
MX2013002122A MX2013002122A (es) 2013-06-05
MX342039B true MX342039B (es) 2016-09-09

Family

ID=45724032

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013002122A MX342039B (es) 2010-08-23 2011-08-23 Composiciones y usos de materiales con actividad antimicrobiana elevada y toxicidad baja referencia cruzada a solicitudes previas.

Country Status (16)

Country Link
US (3) US9017730B2 (es)
EP (1) EP2608800B1 (es)
JP (1) JP5902171B2 (es)
CN (1) CN103260635A (es)
AU (3) AU2011293468B2 (es)
BR (1) BR112013004436A2 (es)
CA (2) CA2809093C (es)
DK (1) DK2608800T3 (es)
ES (1) ES2622498T3 (es)
HU (1) HUE032899T2 (es)
LT (1) LT2608800T (es)
MX (1) MX342039B (es)
PL (1) PL2608800T3 (es)
PT (1) PT2608800T (es)
SG (1) SG188281A1 (es)
WO (1) WO2012027411A2 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103260635A (zh) 2010-08-23 2013-08-21 加利福尼亚大学董事会 具有高抗微生物活性和低毒性的材料的组合物和用途
WO2013142374A1 (en) * 2012-03-23 2013-09-26 Amirobe, Inc. Compositions and uses of antimicrobial materials with tissue-compatible properties
DK3185882T3 (da) 2014-08-29 2020-01-27 Region Midtjylland Positivt ladede copolymerer til anvendelse som antimikrobielle midler
WO2016054432A1 (en) 2014-10-01 2016-04-07 The Regents Of The University Of California Non-ionic and thermoresponsive diblock copolypeptide hydrogels for delivery of molecules and cells
CN106674329B (zh) * 2015-11-05 2021-07-23 程家维 具备抗微生物、抗癌/促进伤口愈合活性的肽及其用途
CN105708592B (zh) * 2016-04-17 2018-04-24 河南科技大学第一附属医院 一种手外科术后的手臂支架
KR20200018400A (ko) * 2017-04-06 2020-02-19 아미크로베, 인코포레이티드. 개선된 성능 및 안전성을 가진 국소적으로 적용된 항균제의 조성물 및 용도
CN111234034B (zh) * 2020-01-22 2021-10-08 国家纳米科学中心 一种调控细胞膜受体的多肽组合物及其制备方法和应用
WO2021207164A1 (en) * 2020-04-08 2021-10-14 Amicrobe, Inc. Compositions and uses of locally applied synthetic amino acid polymers for prevention and treatment of viral infections
CA3188232A1 (en) * 2020-08-10 2022-02-17 Kushee-Nidhi Kush KUMAR Antifungal matrix formed from peptide hydrogels
CN112933108A (zh) * 2021-02-05 2021-06-11 华东理工大学 掺杂多肽聚合物的骨髓腔填充物及在骨髓炎治疗中的用途
CN114748681B (zh) * 2022-04-13 2023-03-10 四川大学 一种可注射自愈合水凝胶敷料及其制备方法、用途

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5856308A (en) * 1996-09-27 1999-01-05 Haemacure Corporation Artificial collagen
US6686446B2 (en) 1998-03-19 2004-02-03 The Regents Of The University Of California Methods and compositions for controlled polypeptide synthesis
AU2001275409A1 (en) 2000-06-08 2001-12-17 The Regents Of The University Of California Methods and compositions for controlled polypeptide synthesis
AU2002345691C1 (en) 2001-06-13 2008-07-24 Massachusetts Institute Of Technology In vivo bioreactors
WO2003054508A2 (en) 2001-10-23 2003-07-03 Anteon Corporation Integrated oxygen generation and carbon dioxide absorption method, apparatus and systems
US20030147958A1 (en) * 2002-01-29 2003-08-07 Cheol-Hee Ahn Biodegradable multi-block copolymers of poly(amino acid)s and poly(ethylene glycol) for the delivery of bioactive agents
US7204997B2 (en) 2002-01-29 2007-04-17 Supratek Pharma Inc. Responsive microgel and methods related thereto
JP2006521355A (ja) * 2003-03-17 2006-09-21 ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア・センター・フオー・テクノロジー・トランスフアー 表面的に両親媒性のポリマー及びオリゴマーならびにそれらの使用
US7329638B2 (en) 2003-04-30 2008-02-12 The Regents Of The University Of Michigan Drug delivery compositions
EP1644382B1 (en) * 2003-07-11 2008-03-05 Theravance, Inc. Cross-linked glycopeptide-cephalosporin antibiotics
AU2006231452B2 (en) 2005-04-01 2011-05-26 Intezyne Technologies, Inc. Polymeric micelles for drug delivery
CN104017083A (zh) 2005-04-15 2014-09-03 亚利桑那癌症治疗公司 用于治疗转移性癌症的治疗肽
JP5329949B2 (ja) 2005-05-31 2013-10-30 エコーレ ポリテクニーク フェデラーレ デ ローザンヌ 遺伝子に基づいた薬物の細胞質送達のためのトリブロックコポリマー
US20070190110A1 (en) * 2006-02-10 2007-08-16 Pameijer Cornelis H Agents and devices for providing blood clotting functions to wounds
US9168329B2 (en) * 2006-09-01 2015-10-27 Wisconsin Alumni Research Foundation Beta-peptides with antifungal activity
JP2010511630A (ja) * 2006-12-01 2010-04-15 ザ リージェンツ オブ ザ ユニバーシティー オブ カリフォルニア 自己組織化ブロックコポリマーのベシクル、ならびにその生成および使用法
US20080312581A1 (en) 2007-06-06 2008-12-18 Biovaluation & Analysis, Inc. Peptosomes for Use in Acoustically Mediated Intracellular Drug Delivery in vivo
WO2009025802A1 (en) * 2007-08-21 2009-02-26 The Regents Of The University Of California Copolymer-stabilized emulsions
EP2400974B1 (en) 2009-02-18 2017-09-06 The Regents of the University of California Synthetic diblock copolypeptide hydrogels for use in the central nervous system
CN103260635A (zh) 2010-08-23 2013-08-21 加利福尼亚大学董事会 具有高抗微生物活性和低毒性的材料的组合物和用途
US9718921B2 (en) 2013-02-26 2017-08-01 The Regents Of The University Of California Amphiphilic derivatives of thioether containing block copolypeptides

Also Published As

Publication number Publication date
AU2016203767A1 (en) 2016-06-23
AU2014213503A1 (en) 2014-09-04
WO2012027411A3 (en) 2012-07-19
CN103260635A (zh) 2013-08-21
AU2011293468A1 (en) 2013-03-14
LT2608800T (lt) 2017-05-10
WO2012027411A9 (en) 2012-05-31
AU2011293468B2 (en) 2014-05-15
DK2608800T3 (da) 2017-05-01
HUE032899T2 (hu) 2017-11-28
JP5902171B2 (ja) 2016-04-13
MX2013002122A (es) 2013-06-05
PL2608800T3 (pl) 2017-08-31
PT2608800T (pt) 2017-05-03
AU2016203767B2 (en) 2018-04-26
EP2608800A2 (en) 2013-07-03
AU2014213503B2 (en) 2016-03-10
US20200288709A1 (en) 2020-09-17
US9017730B2 (en) 2015-04-28
JP2013536242A (ja) 2013-09-19
US20130267458A1 (en) 2013-10-10
EP2608800A4 (en) 2014-01-22
CA2912577C (en) 2019-02-19
CA2809093A1 (en) 2012-03-01
CA2912577A1 (en) 2012-03-01
CA2809093C (en) 2015-11-24
WO2012027411A2 (en) 2012-03-01
US20150366193A1 (en) 2015-12-24
EP2608800B1 (en) 2017-01-18
US10448634B2 (en) 2019-10-22
BR112013004436A2 (pt) 2016-06-21
ES2622498T3 (es) 2017-07-06
SG188281A1 (en) 2013-04-30

Similar Documents

Publication Publication Date Title
MX342039B (es) Composiciones y usos de materiales con actividad antimicrobiana elevada y toxicidad baja referencia cruzada a solicitudes previas.
MX354749B (es) Composiciones de gluconato de clorhexidina, sistemas de resinas y articulos.
EA033311B1 (ru) Производные бензоксаборола в качестве антибактериальных средств
WO2017044894A3 (en) Cartilage-homing peptides
NZ618571A (en) Peptides and their use
EP4014982A3 (en) Composition for inducing proliferation or accumulation of regulatory t cells
EP2583684A4 (en) PEPTIDE WITH ANTIMICROBIAL OR ANTI-INFLAMMATORY ACTIVITY AND PHARMACEUTICAL COMPOSITION COMPRISING THIS PEPTIDE AS AN ACTIVE AGENT
WO2011138678A3 (en) Compositions, gels and foams with rheology modulators and uses thereof
AU2012228355A8 (en) N-(1,2,5-oxadiazol-3-yl)-, N-(tetrazol-5-yl)- and N-(triazol-5-yl)bicycloarylcarboxamides and their use as herbicides
BR112012017473A2 (pt) pirido(1,2-a) pirimidinas, seu uso, bem como composição farmacêutica compreendendo tais compostos
MX342912B (es) Aplicaciones antibacterianas de nanofibras de poli-n-acetilglucosamina.
WO2013105089A8 (en) Anti-inflammatory peptides and use thereof
CA3010564A1 (en) An antibacterial composition and a method of treating staphylococcal infections with the antibacterial composition
NZ606723A (en) Glatiramer acetate molecular weight markers
IL225464A0 (en) 2nd peptides, preparations containing them and their uses
MX2013004711A (es) Composiciones farmaceuticas.
EP2597949A4 (en) SUBMIKROMETERZUSAMMENSETZUNGEN
MX2015008373A (es) Peptidos antimicrobianos, composiciones que los comprende y usos.
BR112012004948A2 (pt) composições e produtos antimicróbicos
EP2569327A4 (en) EIF4E BINDING PEPTIDES
WO2011103524A3 (en) Cyclic tetrapeptides and therapeutic applications thereof
WO2014031982A3 (en) Methods and compositions for treating pain
GB201309927D0 (en) Caspofungin analog, and preparation method and applications thereof
RS53197B (en) OSTEOARTRITIS TREATMENT COMBINATION
WO2019066382A3 (ko) 트리메틸 사이클로헥센 화합물을 포함하는 아디포넥틴 생성 촉진용 조성물

Legal Events

Date Code Title Description
FG Grant or registration